Professor | Yang Ling | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yang Ling
Contact Information	yangling@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Yang Ling

Contact Information

yangling@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	1997.09—2002.07 Clinical Medicine: Xi'an Jiaotong University 2002.09—2005.07 Master's in Genetics: Xi'an Jiaotong University 2005.09—2008.07 PhD in Genetics: Fudan University
Work Experience	2008.07—Present - Fudan University - Lecturer/Associate Professor (2020.10—Present - Secretary and Deputy Director of the Department of Cell and Genetic Medicine) 2014.05—2015.09 - University of Pittsburgh Medical Center - Postdoctoral Researcher
Awards	2019: Shanghai Female Professors Talent Development Fund Teaching Achievement Award, Shanghai 2019: Fudan University Model Couple Award, Fudan University 2019: First Prize in Curriculum Ideological and Political Teaching Plan Competition, Shanghai Medical College of Fudan University 2017: First Prize in Shanghai Teaching Achievement Award, Shanghai 2017: Special Prize in Fudan University Teaching Achievement Award, Fudan University 2015: Best Innovation Award for Outstanding Young Scholars, China Eugenics Science Association 2009: First Prize in Shanghai Teaching Achievement Award, Shanghai

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

1997.09—2002.07 Clinical Medicine: Xi'an Jiaotong University
2002.09—2005.07 Master's in Genetics: Xi'an Jiaotong University
2005.09—2008.07 PhD in Genetics: Fudan University

Work Experience

2008.07—Present - Fudan University - Lecturer/Associate Professor (2020.10—Present - Secretary and Deputy Director of the Department of Cell and Genetic Medicine)
2014.05—2015.09 - University of Pittsburgh Medical Center - Postdoctoral Researcher

Awards

2019: Shanghai Female Professors Talent Development Fund Teaching Achievement Award, Shanghai
2019: Fudan University Model Couple Award, Fudan University
2019: First Prize in Curriculum Ideological and Political Teaching Plan Competition, Shanghai Medical College of Fudan University
2017: First Prize in Shanghai Teaching Achievement Award, Shanghai
2017: Special Prize in Fudan University Teaching Achievement Award, Fudan University
2015: Best Innovation Award for Outstanding Young Scholars, China Eugenics Science Association
2009: First Prize in Shanghai Teaching Achievement Award, Shanghai

Areas of Focus	Molecular Chaperones and Cancer Research Cancer Drug Resistance and Targeted Therapy Research
Publications	MORTALIN-Ca2+ axis drives innate rituximab resistance in diffuse large B-cell lymphoma, Sun Q, Ye Y, Gui AL, Sun XT, Xie SS, Zhan YH, Chen RB, Yan YC, Gu J, Qiu S, Liu W, Zuo J, Zhang QL, Yang L, 2022 Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma, Qiu S, Liu Y, Gui A, Xia Z, Liu W, Gu JJ, Zuo J, Yang L, Zhang Q, 2022 NF-κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin, Li S, Lv M, Qiu S, Meng J, Liu W, Zuo J, Yang L, 2019 p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma, Yang L, Sun X, Ye Y, Lu Y, Zuo J, Liu W, Elcock A, Zhu S, 2019 Multilayer photodynamic therapy for highly effective and safe cancer treatment, Yang L, Zhang S, Ling X, Shao P, Jia N, Bai M, 2017 Salvianolic acid B inhibits mitochondrial dysfunction by up-regulating mortalin, Liu Y, Hu Y, E Q, Zuo J, Yang L, Liu W, 2017 Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK-ERK pathway, Hu Y, Yang L, Yang Y, Han Y, Wang Y, Liu W, Zuo J, 2016 Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer, Zhang S, Yang L, Ling X, Shao P, Wang X, Edwards WB, Bai M, 2015 Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells, Yang L, Li H, Jiang Y, Zuo J, Liu W, 2013 Crosstalk between Raf/MEK/ERK and PI3K/AKT in suppression of Bax conformational change by Grp75 under glucose deprivation conditions, Yang L, Guo W, Zhang Q, Li H, Liu X, Yang Y, Zuo J, Liu W, 2011

Areas of Focus

Molecular Chaperones and Cancer Research
Cancer Drug Resistance and Targeted Therapy Research

Publications

MORTALIN-Ca2+ axis drives innate rituximab resistance in diffuse large B-cell lymphoma, Sun Q, Ye Y, Gui AL, Sun XT, Xie SS, Zhan YH, Chen RB, Yan YC, Gu J, Qiu S, Liu W, Zuo J, Zhang QL, Yang L*, 2022
Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma, Qiu S, Liu Y, Gui A, Xia Z, Liu W, Gu JJ, Zuo J, Yang L*, Zhang Q*, 2022
NF-κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin, Li S, Lv M, Qiu S, Meng J, Liu W, Zuo J, Yang L*, 2019
p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma, Yang L, Sun X, Ye Y, Lu Y, Zuo J, Liu W, Elcock A, Zhu S, 2019
Multilayer photodynamic therapy for highly effective and safe cancer treatment, Yang L, Zhang S, Ling X, Shao P, Jia N, Bai M, 2017
Salvianolic acid B inhibits mitochondrial dysfunction by up-regulating mortalin, Liu Y, Hu Y, E Q, Zuo J, Yang L*, Liu W*, 2017
Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK-ERK pathway, Hu Y, Yang L, Yang Y, Han Y, Wang Y, Liu W, Zuo J, 2016
Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer, Zhang S, Yang L, Ling X, Shao P, Wang X, Edwards WB, Bai M, 2015
Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells, Yang L, Li H, Jiang Y, Zuo J, Liu W, 2013
Crosstalk between Raf/MEK/ERK and PI3K/AKT in suppression of Bax conformational change by Grp75 under glucose deprivation conditions, Yang L, Guo W, Zhang Q, Li H, Liu X, Yang Y, Zuo J, Liu W, 2011

Molecular Chaperones Cancer Drug Resistance Targeted Therapy Genetics Cell Biology Oncology Molecular Biology Biochemistry Research

Guoheng Xu - Peking University

Wei Zhen Zhang - Peking University

Guo-Gang Xing - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us